Ginkgo bioworks and novo nordisk to collaborate on expression systems for pharmaceutical products

Boston , june 7, 2022 /prnewswire/ --  ginkgo bioworks (nyse: dna), the leading horizontal platform for cell programming, today announced a collaboration with novo nordisk , a leading global healthcare company, to create novel expression hosts for pharmaceutical products. today, hundreds of millions of people are living with diabetes, obesity, and other serious chronic diseases, putting a strain on individuals, families, and healthcare systems.
DNA Ratings Summary
DNA Quant Ranking